Windtree Therapeutics Inc (NASDAQ:WINT) price on Thursday, March 20, rose 28.99% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.18.
A look at the stock’s price movement, the close in the last trading session was $1.69, moving within a range at $1.94 and $3.48. The beta value (5-Year monthly) was 0.68. Turning to its 52-week performance, $737.43 and $1.62 were the 52-week high and 52-week low respectively. Overall, WINT moved -56.96% over the past month.
Windtree Therapeutics Inc’s market cap currently stands at around $1.53 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-25.
Turning to the stock’s technical picture we see that short term indicators suggest on average that WINT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend WINT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
WINT’s current price about -13.49% and -64.87% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 29.78, while 7-day volatility ratio is 24.06% and 17.69% in the 30-day chart. Further, Windtree Therapeutics Inc (WINT) has a beta value of 0.82, and an average true range (ATR) of 0.71.
If we refocus on Windtree Therapeutics Inc (NASDAQ:WINT), historical trading data shows that trading volumes averaged 12.26 over the past 10 days and 350.17K over the past 3 months. The company’s latest data on shares outstanding shows there are 0.75 million shares.
The 0.13% of Windtree Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 0.84% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 82996.0 on 2025-02-28, giving us a short ratio of 0.29. The data shows that as of 2025-02-28 short interest in Windtree Therapeutics Inc (WINT) stood at 1108.0 of shares outstanding, with shares short rising to 3480.0 registered in 2025-01-31. Current price change has pushed the stock -87.52% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the WINT stock continues to rise going into the next quarter.
